Are Heart Transplants Possible? Vital Second Ops

Mustafa Çelik

Mustafa Çelik

Magnero Content Team
...
Views
Read Time
Are Heart Transplants Possible? Vital Second Ops
Are Heart Transplants Possible? Vital Second Ops 4

Getting a heart transplant can save lives. But, some people might need a second transplant. This could be because the first transplant failed, was rejected, or because of heart disease. The idea of getting a second heart transplant is very complex.

About 1-3% of heart transplants are second transplants each year. Deciding on a second transplant is very careful. It looks at the patient’s health and the risks and benefits of the surgery. New medical tech and organ donation for heart transplant have made second transplants more possible.

Key Takeaways

  • Retransplantation accounts for about 1-3% of all heart transplants performed annually.
  • Graft failure, rejection, or coronary artery disease are common reasons for a second heart transplant.
  • The decision to undergo retransplantation involves careful evaluation of the patient’s overall health.
  • Recent advances in medical technology have improved the heart transplant success rate.
  • Organ donation plays a critical role in making hearts available for transplant.

The Current Landscape of Heart Transplantation

SEP 9069 image 2 LIV Hospital
Are Heart Transplants Possible? Vital Second Ops 5

The field of heart transplantation is growing fast. This is thanks to better treatments and matching organs. These changes have made life after a transplant better for patients.

Statistical Overview of Heart Transplants in the United States

In the U.S., heart transplant numbers show a complex story. About 3,700 heart transplants happen every year. Survival rates have gone up, with more people living longer after a transplant.

But, the success rate for second transplants is much lower. Only 48% of people survive a year after a second transplant. This is compared to 79% for those getting a transplant for the first time.

The number of transplants depends on donor hearts and waiting list size. The Organ Procurement and Transplantation Network (OPTN) tracks these numbers. They give us a clear view of heart transplant trends.

Historical Development of Transplant Procedures

The history of heart transplants is filled with key moments. The first transplant was done in 1967 by Medical Expert. Ever after, surgery, treatments, and care have gotten better.

New drugs to prevent rejection have been a big help. They’ve made it possible for more people to live longer after a transplant. These changes have made heart transplants a real option for those with failing hearts.

Are Heart Transplants Possible for All Patients?

SEP 9069 image 3 LIV Hospital
Are Heart Transplants Possible? Vital Second Ops 6

Heart transplant eligibility is based on a detailed review of a patient’s health history and current condition. This review is key to determining if a patient can safely undergo the transplant.

Eligibility Requirements for First-Time Recipients

To qualify for a heart transplant, patients must meet certain criteria. They need to have severe heart failure and be on the best possible treatment. They also must have no other treatment options left.

The evaluation looks at the patient’s overall health. This includes their heart and kidney function, and how well they can recover after the transplant.

Criteria

Description

End-stage heart failure

Advanced heart failure with significant symptoms at rest

Optimal medical therapy

Patient is on the best possible medical treatment for heart failure

No other viable options

No alternative treatments available, such as mechanical circulatory support or surgical interventions

Conditions That Necessitate Heart Transplantation

Heart transplant is considered for severe heart conditions that other treatments can’t fix. This includes advanced heart failure, certain types of cardiomyopathy, and severe coronary artery disease.

  • Advanced heart failure
  • Severe cardiomyopathy
  • Coronary artery disease not amenable to revascularization

Contraindications for Transplant Surgery

Some conditions make heart transplantation not suitable. These include active cancer, severe kidney or liver disease, and significant pulmonary hypertension. These conditions can raise the risks of the transplant and affect survival.

The decision to have a heart transplant is complex. It involves a detailed evaluation of the patient’s condition. A team of healthcare professionals makes this decision, weighing the benefits and risks of the transplant.

The Heart Transplant Procedure Explained

Getting a heart transplant is a big deal. It needs careful planning and doing. The steps range from checking if you’re ready to taking care of you after the surgery.

Pre-Surgical Evaluation and Preparation

Before the big day, doctors check you out thoroughly. They do blood tests, imaging, and heart checks. This makes sure you’re healthy enough and the transplant might work.

Key factors assessed during the pre-surgical evaluation include:

  • Cardiac function and overall heart health
  • Presence of any infections or underlying conditions
  • Compatibility with the donor heart
  • Patient’s overall physical and mental well-being

Step-by-Step Surgical Process

The surgery to get a new heart is very detailed. It involves taking out your old heart and putting in a new one. Here’s what happens:

  1. Doctors give you anesthesia so you won’t feel pain.
  2. You’re connected to a machine that keeps your blood flowing and oxygen levels up.
  3. Your old heart is carefully removed, trying not to damage nearby tissues.
  4. The new heart is put in, making sure all blood vessels are connected right.
  5. Your new heart starts beating, and doctors watch how it’s doing.

Critical Post Operative Care

After the surgery, you’ll be in the ICU. This is where doctors keep a close eye on you to avoid problems. They focus on:

Care Aspect

Description

Monitoring

Watching your vital signs and heart function closely

Immunosuppression

Medicine to stop your body from rejecting the new heart

Infection Prevention

Steps to lower the chance of getting sick

Good care after surgery is key. It helps avoid risks of heart transplant surgery and makes sure the transplant works well in the long run.

Navigating the Organ Donation Process

For patients waiting for heart transplants, understanding the organ donation process is key. This process matches donors with recipients, focusing on those who need a transplant the most.

How the Heart Allocation System Works

The heart allocation system puts patients in order based on their medical needs and wait time. It’s vital for matching donor hearts with the right recipients. The system looks at how sick the patient is and their chances of survival without a transplant.

Key Factors in Heart Allocation:

  • Medical Urgency: Patients with severe heart failure get priority.
  • Waiting Time: Those waiting longer are considered next.
  • Geographic Location: Hearts are given to patients in the same area to reduce wait time.

Waiting List Considerations

Patients on the waiting list are ranked by their medical urgency and other factors. The list changes as patients’ conditions evolve. Being on the list means being ready for a transplant at any moment and following a strict medical routine.

Status

Description

Priority Level

Status 1

Critical condition, requiring immediate transplant

High

Status 2

Stable but requiring transplant in the near future

Medium

Status 3

Stable, not requiring immediate transplant

Low

Living with a Ventricular Assist Device While Waiting

Many patients on the waiting list use a ventricular assist device (VAD) to help their heart. VADs improve heart function, making life better and increasing survival chances until a transplant.

Managing a VAD is complex, needing regular checks and strict medical care. Patients must also be ready for any complications and ongoing medical needs.

First Heart Transplant Success Rates and Outcomes

The field of heart transplantation has grown, with first-time patients seeing better results. This is thanks to new care methods and treatments. These advancements have greatly improved the success and outcomes for those getting a heart transplant for the first time.

Short-Term Survival Statistics

About 79% of first-time heart transplant patients live for a year after the transplant. This shows how well care has improved and how effective new treatments are.

Improved surgical techniques and personalized care have helped a lot. Most first-time transplant patients make it past the first year. This is a good start for their long-term survival.

Long-Term Prognosis Factors

Many things affect how well a heart transplant patient will do long-term. These include how well the new heart works, if the patient takes their medicine, and if they have other health issues. Managing these well is key to a good long-term outcome.

A study found that long-term survival depends on not having serious heart problems and keeping the right amount of medicine. Keeping an eye on these things and making changes as needed is important for a good long-term outlook.

Quality of Life After Transplantation

Heart transplant patients’ quality of life has gotten much better. Many are now living active lives. The new treatments have been key in improving both survival rates and quality of life.

“The improvement in quality of life for heart transplant recipients is a significant achievement, reflecting the progress made in transplantation medicine.” – A Transplant Specialist

Patients often feel better and can do more things. They can enjoy life more fully because of these improvements.

When Heart Transplants Fail: Understanding the Causes

It’s key to know why heart transplants fail to better care for patients. Heart transplant failure can happen for many reasons. It’s important to spot and fix these problems quickly.

Primary Graft Dysfunction

Primary graft dysfunction (PGD) is a big reason for early heart transplant failure. It makes the heart work poorly without other obvious reasons. PGD is very serious and needs quick medical help.

We don’t know all about PGD, but we think donor and recipient health, how the organ is kept, and care during surgery matter. Spotting and treating PGD early is key to saving lives.

Acute and Chronic Rejection Mechanisms

Rejection is a big problem after heart transplants. It can be acute or chronic. Acute rejection happens when the body sees the new heart as foreign and tries to fight it. This often happens in the first few months.

Chronic rejection is a long-term issue that can cause the heart to fail. It leads to scarring and artery problems in the transplanted heart. Medicine to stop the immune system from attacking the heart is very important.

Cardiac Allograft Vasculopathy (Transplant Coronary Artery Disease)

Cardiac allograft vasculopathy (CAV) is a type of chronic rejection that affects the heart’s arteries. It’s a big reason for long-term heart transplant failure and death.

CAV causes the arteries to narrow and thicken, leading to heart problems. Many things can cause CAV, including the immune system and other factors.

Knowing why heart transplants fail is vital for better care. By tackling PGD, acute and chronic rejection, and CAV, doctors can help patients live longer with their new heart.

Second Heart Transplants: Medical Reality and Frequency

Second heart transplants are a real option in medicine, though rare. About 1-3% of heart transplants are second ones. They happen when the first transplant fails, is rejected, or due to artery disease.

Statistical Prevalence of Retransplantation

Heart retransplants are a small part of all heart transplants. Only about 1-3% of them are second transplants. This low number is because doctors carefully choose who gets a second transplant.

Deciding on a second transplant is complex. Doctors look at the patient’s health and specific medical signs. They consider why the first transplant failed, the patient’s current health, and if a second transplant could work.

Typical Timeframes Between First and Second Transplants

The time between the first and second transplant varies. It depends on why the first transplant failed. If it was due to rejection or dysfunction, a second transplant might happen soon. But if it’s due to artery disease, it might take longer.

  • Early retransplantation: Often needed for acute rejection or dysfunction.
  • Late retransplantation: May be for conditions like artery disease that take time to develop.

Medical Indicators for Retransplantation

Doctors look for signs like graft failure, severe rejection, and artery disease for a second transplant. The process to decide is thorough. It includes looking at the patient’s medical history, current health, and chances of recovery.

Important signs for a second transplant are:

  1. Graft failure or severe dysfunction
  2. Recurrent or severe rejection episodes
  3. Significant cardiac allograft vasculopathy

These signs help doctors decide if a second transplant is right for a patient. They aim to make the best choice for the patient’s health.

The Evaluation Process for Second Heart Transplant Candidates

Candidates for a second heart transplant face a detailed evaluation. This checks their health and medical history. It’s key to see if they’re ready for another transplant.

Risk Stratification and Assessment

Risk stratification is a big part of the evaluation. It looks at the patient’s risk factors, like past surgeries and health issues. It helps spot possible problems during or after the transplant.

Key factors considered in risk stratification include:

  • The patient’s current health status and any significant changes
  • Previous surgical complications or reactions to immunosuppressive therapy
  • Other serious health conditions that could affect the transplant’s success

Ethical Considerations in Organ Reallocation

Deciding on a second heart transplant raises ethical questions. It’s about balancing the chance to save a life with the risks. It’s a tough decision that needs careful thought.

“The ethical dilemma lies in ensuring fairness and equity in the allocation of donor hearts, particular for patients needing a second transplant.”

Institutional Protocols for Retransplantation Approval

Each transplant center has its own rules for approving a second transplant. A team of doctors, including cardiologists and surgeons, reviews each case. They make sure the decision to transplant again is well thought out.

The evaluation process is complex. It looks at the patient’s medical history, current health, and chances of success.

Survival Rates After Second Heart Transplantation

Heart retransplantation survival rates are key for those needing a second transplant. The thought of another big surgery is scary. But knowing the survival stats can help patients and families make better choices.

Comparative Analysis with First-Time Recipients

Survival rates for second heart transplant patients are lower than for first-timers. First-time recipients have a 79% one-year survival rate, while second-timers have about 48%. This shows the extra challenges of getting a second transplant.

Transplant Type

1-Year Survival Rate

First Heart Transplant

79%

Second Heart Transplant

48%

Factors That Improve Second Transplant Outcomes

Even with lower survival rates, some factors can help second transplant patients. These include:

  • Careful patient selection
  • Optimal immunosuppressive therapy
  • Close follow-up care

New immunosuppressive treatments and better matching have helped improve survival rates. Healthcare teams can increase success chances for second transplant patients by focusing on these areas.

Long-Term Survival Possibilities

Though immediate survival rates for second transplants are lower, some patients live long after. Some have survived 10 years or more after their second transplant. These stories highlight the need for ongoing medical progress and tailored care.

Heightened Risks Associated with Retransplantation

Getting a second heart transplant is a complex journey. It comes with higher risks, like surgical problems and infections. These risks are more common in retransplant patients.

Increased Surgical Complications

The second transplant surgery is more complex. This is because of the patient’s past surgeries. The first transplant can cause adhesions, making the second surgery riskier.

Common surgical complications include:

  • Bleeding and hemorrhage
  • Infection at the surgical site
  • Adhesions and scarring
  • Cardiac dysfunction post-transplant

Enhanced Susceptibility to Infections

Patients getting a second transplant are more at risk for infections. This is because they are on immunosuppressive drugs. These drugs help prevent rejection but also increase infection risk.

“The immunosuppressed state of retransplant patients necessitates careful management to balance the risk of rejection against the risk of infection.”

Preventive measures include using antibiotics and watching for infection signs.

Elevated Rejection Probability

Rejection is a big worry in second transplants. It can happen anytime after the transplant. It needs careful management with immunosuppressive drugs.

Rejection Type

Description

Management Strategy

Hyperacute Rejection

Occurs within minutes to hours post-transplant

Pre-transplant desensitization, careful donor-recipient matching

Acute Rejection

Can occur at any time post-transplant

Immunosuppressive therapy adjustment

Chronic Rejection

Gradual decline in graft function over time

Long-term immunosuppression, monitoring for graft dysfunction

Picking the right patient, using careful surgery, and good post-op care are key. They help lower the risks of a second transplant.

Advancements in Immunosuppressive Therapies

Immunosuppressive therapies have greatly improved for heart transplant patients. This has led to better quality of life and longer survival rates. These treatments are key in preventing rejection and ensuring the success of heart transplants.

Evolution of Anti-Rejection Medication Protocols

The development of anti-rejection medication has been a major step forward. Early treatments were broad and often caused serious side effects. Now, we have more targeted therapies that reduce rejection risk and side effects.

Calcineurin inhibitors have been a big leap, providing better protection against rejection. Mammalian target of rapamycin (mTOR) inhibitors are also used for those who can’t take calcineurin inhibitors. This makes treatment more personalized.

Personalized Immunosuppression Strategies

Personalized immunosuppression is becoming more common. It involves tailoring treatments to each patient’s needs. Genetic testing and biomarker analysis help guide these personalized plans, leading to better treatment.

This approach not only makes treatments more effective but also easier for patients to follow. It simplifies medication regimens, improving patient compliance.

Managing Side Effects of Long-Term Immunosuppression

Long-term use of immunosuppressants can lead to side effects like infections and cancer. It’s important to manage these risks to keep transplant patients healthy.

Managing these risks includes regular monitoring and adjusting treatments as needed. Patient education is also key. It helps patients recognize and report any side effects quickly.

Improved Organ Matching Techniques for Repeat Transplants

Advances in organ matching have greatly improved outcomes for patients getting repeat heart transplants. The field of heart transplantation has seen big steps forward in matching organs. These steps have been key in making repeat transplants more successful.

Advanced Tissue Typing Technologies

Advanced tissue typing technologies have changed how we match donor hearts to recipients. These technologies help match human leukocyte antigen (HLA) types more precisely. This reduces the chance of rejection and boosts graft survival.

Precision in tissue typing is very important in retransplantation. Previous transplants or other factors can make matching harder. New technologies, like molecular typing and virtual cross-matching, have made matching more accurate and faster.

Cross-Matching Innovations

Cross-matching innovations have also been key in improving organ matching for repeat transplants. Old cross-matching methods had big limitations. They needed the physical presence of recipient serum and donor cells.

Now, with virtual cross-matching using flow cytometry and solid-phase assays, these issues are solved. This allows for quicker and more accurate finding of compatible donors.

These new methods have greatly lowered the risk of acute rejection. They have also improved long-term results for retransplant patients.

Addressing Sensitization Challenges in Retransplant Patients

Retransplant patients often face sensitization from previous exposure to non-self HLA antigens. This can be from blood transfusions, pregnancies, or previous transplants. This sensitization makes the immune system more likely to reject a new graft.

To tackle sensitization, a mix of strategies is needed. This includes desensitization therapies and picking donors carefully with advanced tissue typing and cross-matching. These steps help reduce the risk of rejection, making repeat heart transplants more successful.

Recovery and Rehabilitation After Multiple Heart Transplants

The journey to recovery after multiple heart transplants is complex. It needs a detailed plan from many experts to help patients do well.

Specialized Physical Rehabilitation Protocols

Physical rehab is key after multiple heart transplants. Specialized programs help patients get stronger and improve their heart health. These plans are made just for each patient and might include exercises, therapy, and advice on living a healthy lifestyle.

These programs tackle the special challenges of having had more than one transplant. They focus on personalized care to boost patients’ strength and life quality.

Medication Management Complexities

Managing medicines is also very important after multiple heart transplants. Patients take many drugs to stop their body from rejecting the new heart. It’s important to watch and adjust these medicines carefully to avoid problems.

Managing these medicines is tricky. Doctors must balance keeping the heart safe with avoiding bad side effects. They teach patients about their medicines and watch for any issues.

Long-Term Monitoring Requirements

Long-term checks are essential for those with multiple heart transplants. Regular visits help catch problems early, like rejection or heart issues. Regular checks also let doctors adjust treatment plans to keep patients healthy.

Patients should also play a big role in their care. They should follow healthy living tips and tell their doctors about any changes. This teamwork helps patients live better lives after a transplant.

The Psychological Journey Through Multiple Heart Transplants

Going through multiple heart transplants is a tough mental journey. It requires a lot of strength and the ability to adapt. The process is not just about getting better physically. It’s also about dealing with the emotional and mental hurdles that come with such a big medical step.

Coping with Medical Uncertainty

One big mental challenge for patients with multiple heart transplants is dealing with medical uncertainty. The unpredictability of results, possible complications, and the need for ongoing medical checks can make people very anxious and stressed. To manage this uncertainty, patients often turn to support systems and resources for help.

Good ways to cope include:

  • Mindfulness and relaxation techniques to lower stress and anxiety.
  • Counseling and therapy to meet emotional and mental needs.
  • Support groups where people can share their stories and connect with others facing similar issues.

Support Systems and Resources

Support systems and resources are key in helping patients deal with the mental challenges of multiple heart transplants. These can be family and friends, healthcare teams, support groups, and online communities. Having access to a wide range of support can greatly help patients cope with the mental demands of their treatment.

Important parts of effective support include:

  1. Emotional support to handle feelings of fear, anxiety, and sadness.
  2. Practical help with everyday tasks and responsibilities.
  3. Informational resources to teach patients about their condition and treatment choices.

Identity and Emotional Challenges

Multiple heart transplants can also affect a person’s identity and emotions. Patients might feel grateful for a second chance at life but also worried about the future. The process can make a person question who they are, which is hard if they’ve been sick for a long time. Finding a new sense of self and adjusting to a new reality is a big part of the mental journey.

To tackle these issues, patients might find it helpful to:

  • Psychological counseling to explore and deal with identity problems.
  • Rehabilitation programs that help with both physical and emotional healing.
  • Peer support from others who have gone through similar things.

In conclusion, the mental journey through multiple heart transplants is complex and involves many challenges. By understanding these challenges and using support systems and resources, patients can better handle this journey and have a more positive outcome.

Alternative Options When Retransplantation Isn’t Possible

When a second heart transplant is not an option, patients and doctors look for other ways to help. These alternatives can make life better and sometimes even longer.

Mechanical Circulatory Support Devices

Mechanical Circulatory Support (MCS) devices are key for those who can’t get a retransplant. They help the heart pump better, easing heart failure symptoms and boosting health.

  • Left Ventricular Assist Devices (LVADs): LVADs are put in the chest and linked to a controller. They help the heart pump blood more efficiently.
  • Total Artificial Hearts (TAHs): TAHs replace the heart entirely. They’re for those with severe heart failure.

Experimental Therapies and Clinical Trials

Some patients might join clinical trials or try new treatments. These cutting-edge options aim to better heart function and health.

Examples include:

  1. Stem cell therapy, which tries to fix damaged heart tissue.
  2. Gene therapy, which targets the genetic causes of heart failure.

Palliative Care Approaches

Palliative care helps with heart failure symptoms and stress, at any disease stage. A team of healthcare experts works together to enhance life quality.

Palliative care includes:

  • Managing symptoms like pain and shortness of breath.
  • Support for emotional and spiritual well-being of patients and families.
  • Help with making medical decisions and planning for the future.

Specialized Medical Centers for Complex Heart Transplantation

Complex heart transplantations need a high level of expertise. Only specialized medical centers can provide this. They have the latest facilities and teams with years of experience.

Institutional Expertise Requirements

These centers must have deep knowledge to handle complex heart transplants. They need to know the latest in transplant tech, immunosuppressive treatments, and post-op care.

Institutional expertise comes from lots of experience, ongoing learning, and following best practices. Centers that do many transplants often have better results because of their honed skills and efficient processes.

Liv Hospital’s Approach to Transplant Excellence

Liv Hospital is a top example of a specialized center for heart transplants. They focus on personalized patient care, use the latest tech, and have a team that works together for the best results.

They do detailed pre-transplant checks, use advanced matching methods, and provide careful post-op care. Their team supports patients and their families every step of the way.

Multidisciplinary Team Importance

A multidisciplinary team is key for complex heart transplant success. This team includes cardiologists, surgeons, immunologists, and more. They work together to tackle the many challenges of heart transplants.

This team approach leads to better patient outcomes, better handling of complications, and happier patients. By combining their knowledge, they create detailed plans that meet each patient’s unique needs.

In summary, centers like Liv Hospital are essential for complex heart transplants. Their deep knowledge, dedication to excellence, and use of teams are vital for the best patient results.

Conclusion: The Future of Multiple Heart Transplantations

The world of heart transplantation is changing fast. This is thanks to new research and medical tech. We see a bright future for patients needing more than one heart transplant.

New treatments and better ways to match organs have helped heart transplant patients a lot. More research will keep making things better. This means better lives for those needing multiple transplants.

Thanks to new organ matching and care plans, the outlook is getting better. We expect to see more people living longer, happier lives after multiple transplants. The field is moving forward, and so are the chances for these patients.

The future of multiple heart transplants is exciting. It’s all thanks to new discoveries and research. Patients and doctors can look forward to better treatments and care.

FAQ

What is heart retransplantation?

Heart retransplantation is a rare and complex procedure. It’s for patients who have failed their first heart transplant. This can happen due to graft failure, rejection, or coronary artery disease.

How common are heart retransplantations?

Heart retransplantations make up about 1-3% of all heart transplants each year.

What are the eligibility criteria for a heart transplant?

To get a heart transplant, a patient must go through a detailed evaluation. This looks at their medical history and current health. Conditions like advanced age or severe kidney or liver disease might make a transplant not possible.

What is the heart transplant procedure?

The procedure starts with removing the diseased heart. Then, the donor heart is implanted. After that, the patient needs careful post-operative care to manage any complications and ensure a good outcome.

How does the organ donation process work for heart transplants?

The organ donation system prioritizes patients based on their medical urgency and waiting time. This ensures that those who need a transplant the most get one as soon as possible.

What are the success rates for first-time heart transplant recipients?

First-time heart transplant recipients have a one-year survival rate of about 79%.

Why do heart transplants fail?

Heart transplants can fail for several reasons. These include primary graft dysfunction, acute and chronic rejection, and cardiac allograft vasculopathy.

Can you have a second heart transplant?

Yes, second heart transplants are possible. They are rare and usually done due to graft failure, rejection, or coronary artery disease.

What are the survival rates after a second heart transplant?

The survival rate for second heart transplants is lower. It’s about 48% at one year.

What are the risks associated with retransplantation?

Retransplantation comes with higher risks. These include surgical complications, increased infection risk, and higher rejection probability.

How have immunosuppressive therapies evolved for heart transplant patients?

Immunotherapy for heart transplant patients has improved. Now, treatments are more personalized and focus on managing long-term side effects.

What are the alternative options when retransplantation isn’t possible?

When retransplantation isn’t an option, patients have other choices. These include mechanical circulatory support devices, experimental therapies, and palliative care.

What is the importance of specialized medical centers for complex heart transplantation?

Specialized centers are key for complex heart transplants. They have the expertise and a team approach. This includes careful patient selection, optimal immunosuppressive therapy, and close follow-up care.

References

  1. Outcomes in recipients of combined heart‑kidney transplantation: Multiorgan, same‑donor transplant study of the International Society of Heart and Lung Transplantation/United Network for Organ Sharing Scientific Registry. Transplantation. 1997 Mar 27;63(6):861‑7. doi:10.1097/00007890‑199703270‑00012. PMID: 9089227. (PubMed)
  2. Ensley RD, Hunt S, Taylor DO, Renlund DG, Menlove RL, Karwande SV, O’Connell JB, Barr ML, Michler RE, Copeland JG, et al. Predictors of survival after repeat heart transplantation. The Registry of the International Society for Heart and Lung Transplantation, and Contributing Investigators. J Heart Lung Transplant. 1992 May‑Jun;11(3 Pt 2):S142‑158. PMID: 1622993. (PubMed)
  3. UNOS. UNOS Data and Transplant Statistics. United Network for Organ Sharing. Available from: https://unos.org/data/ (UNOS)
  4. (2022) Heart Chapter, Annual Data Report. Scientific Registry of Transplant Recipients. U.S. Department of Health & Human Services. Available from: https://srtr.transplant.hrsa.gov/ADR/Chapter?name=Heart&year=2022
  5. (2024) “xxx” [Article title unavailable]. Circulation: Heart Failure. DOI:10.1161/CIRCHEARTFAILURE.124.012272. Available from: https://www.ahajournals.org/doi/10.1161/CIRCHEARTFAILURE.124.012272

National Center for Biotechnology Information. Evidence-Based Medical Insight. Retrieved from https://pubmed.ncbi.nlm.nih.gov/1622993/

Trusted Worldwide
30
Years of
Experience
30 Years Badge

With patients from across the globe, we bring over three decades of medical

LIV Hospital Expert Healthcare
Patient Reviews
Reviews from 9,651
4,9

Get a Free Quote

Response within 2 hours during business hours

Clinics/branches
Was this content helpful?
Your feedback helps us improve.
What did you like?
Share more details about your experience.
You must give consent to continue.

Thank you!

Your feedback has been submitted successfully. Your input is valuable in helping us improve.

Our Doctors

Prof. MD. Ziya Akbulut

Prof. MD. Ziya Akbulut

MD. RİFAH HEMİDOV

MD. RİFAH HEMİDOV

Prof. MD. Selçuk Güneş

Prof. MD. Selçuk Güneş

MD. Vefa Abasguliyeva

Op. Md. İdris Kıvanç Cavıldak

Op. Md. İdris Kıvanç Cavıldak

Assoc. Prof. MD. Kaya Turan

Assoc. Prof. MD. Kaya Turan

Prof. MD. Musa Kazım Çağlar

Prof. MD. Musa Kazım Çağlar

Spec. MD. Mehmet Mustafa Anlaş

Spec. MD. Mehmet Mustafa Anlaş

Asst. Prof. MD. Muhammet Bilici

Asst. Prof. MD. Muhammet Bilici

Spec. MD. Zeliha Sırtaş

Spec. MD. Zeliha Sırtaş

Asst. Prof. MD. Onuralp Çalışkan

Asst. Prof. MD. Onuralp Çalışkan

Assoc. Prof. MD.  Hüseyin Murat Mutuş

Assoc. Prof. MD. Hüseyin Murat Mutuş

Your Comparison List (you must select at least 2 packages)